Christine Voellenkle
Overview
Explore the profile of Christine Voellenkle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
541
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Izzo M, Battistini J, Golini E, Voellenkle C, Provenzano C, Orsini T, et al.
Clin Transl Med
. 2025 Feb;
15(2):e70227.
PMID: 39956955
Background: Myotonic dystrophy type 1 (DM1) is a genetic multisystemic disease, characterised by pleiotropic symptoms that exhibit notable variability in severity, nature and age of onset. The genetic cause of...
2.
Udugampolage N, Frolova S, Taurino J, Pini A, Martelli F, Voellenkle C
Int J Mol Sci
. 2024 Jul;
25(13).
PMID: 39000474
Marfan syndrome (MFS) is a rare congenital disorder of the connective tissue, leading to thoracic aortic aneurysms (TAA) and dissection, among other complications. Currently, the most efficient strategy to prevent...
3.
Made A, Bibi A, Garcia-Manteiga J, Tascini A, Piella S, Tikhomirov R, et al.
Cells
. 2023 Nov;
12(21).
PMID: 37947656
Noncoding RNAs (ncRNAs), which include circular RNAs (circRNAs) and microRNAs (miRNAs), regulate the development of cardiovascular diseases (CVD). Notably, circRNAs can interact with miRNAs, influencing their specific mRNA targets' levels...
4.
Voellenkle C, Fuschi P, Mutoli M, Carrara M, Righini P, Nano G, et al.
Cells
. 2022 Nov;
11(22).
PMID: 36428974
Redox imbalance of the endothelial cells (ECs) plays a causative role in a variety of cardiovascular diseases. In order to better understand the molecular mechanisms of the endothelial response to...
5.
Cardinali B, Provenzano C, Izzo M, Voellenkle C, Battistini J, Strimpakos G, et al.
Mol Ther Nucleic Acids
. 2022 Jan;
27:184-199.
PMID: 34976437
CRISPR/Cas9-mediated therapeutic gene editing is a promising technology for durable treatment of incurable monogenic diseases such as myotonic dystrophies. Gene-editing approaches have been recently applied to and models of myotonic...
6.
Zaccagnini G, Greco S, Voellenkle C, Gaetano C, Martelli F
Antioxid Redox Signal
. 2021 Sep;
36(10-12):685-706.
PMID: 34521246
microRNA-210 (miR-210) is the master hypoxia-inducible miRNA (hypoxamiR) since it has been found to be significantly upregulated under hypoxia in a wide range of cell types. Gene ontology analysis of...
7.
Zaccagnini G, Greco S, Longo M, Maimone B, Voellenkle C, Fuschi P, et al.
Cell Death Dis
. 2021 May;
12(6):507.
PMID: 34006827
No abstract available.
8.
Zaccagnini G, Greco S, Longo M, Maimone B, Voellenkle C, Fuschi P, et al.
Cell Death Dis
. 2021 May;
12(5):435.
PMID: 33934122
Hypoxia-induced miR-210 is a crucial component of the tissue response to ischemia, stimulating angiogenesis and improving tissue regeneration. Previous analysis of miR-210 impact on the transcriptome in a mouse model...
9.
Baldini E, Testa E, Voellenkle C, De Domenico E, Cianfarani F, Martelli F, et al.
J Dermatol Sci
. 2020 May;
98(3):186-194.
PMID: 32402513
Background: Clinical skin manifestations are common in diabetes; however, molecular mechanisms underlying such defects are largely unknown. Several findings indicate a role for microRNAs (miRNAs) in skin homeostasis. Objective: To...
10.
Zaccagnini G, Maimone B, Fuschi P, Longo M, da Silva D, Carrara M, et al.
Int J Mol Sci
. 2019 Dec;
21(1).
PMID: 31878120
Critical limb ischemia is the most serious form of peripheral artery disease, characterized by severe functional consequences, difficult clinical management and reduced life expectancy. The goal of this study was...